Transaction valued at $156.00 per Hillrom Share for an All-Cash Purchase Price of $10.5 Billion
Brings together two leading medical technology companies to broaden access to care in the hospital, home and
Gainers
RenovoRx, Inc. (NASDAQ: RNXT) climbed 107.8% to close at $16.02 on Monday after the company was granted FDA clearance for ‘Catheter, Intravascular Occluding, Temporary.’ The company recently priced its IPO at $9 per unit.
The Wall Street Journal reported that Baxter International Inc (NYSE:BAX) is reportedly in advanced talks to Hill-Rom Holdings Inc (NYSE:HRC) for about $10 billion,…